Lakefront Biotherapeutics (LKFT) Goodwill & Intangibles (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Goodwill & Intangibles for 13 consecutive years, with $4.0 million the latest figure, recorded in Q1 2026.

• Quarterly Goodwill & Intangibles fell 98.46% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 98.46% YoY) and the FY2025 annual result came in at $4.4 million, down 98.36% from the prior year.
• Goodwill & Intangibles declined to $4.0 million in Q1 2026 per LKFT's latest filing, from $4.4 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for LKFT reached as high as $280.6 million in Q4 2022 and fell as low as $4.0 million in Q1 2026.
• A 5-year average of $183.4 million and a median of $239.6 million in 2023 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles jumped 322.32% — and 2026, when it sank 98.46%.
• Year by year, Goodwill & Intangibles stood at $280.6 million in 2022, then fell by 0.69% to $278.6 million in 2023, then declined by 4.07% to $267.3 million in 2024, then sank by 98.36% to $4.4 million in 2025, then fell by 9.47% to $4.0 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $4.0 million, $4.4 million, and $11.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.